Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.

Nitric oxide (NO) stimulates cGMP synthesis by activating its intracellular receptor, soluble guanylyl cyclase (sGC). It is a currently prevailing concept that No and cGMP inhibits platelet function. However, the data supporting the inhibitory role of NO/sGC/cGMP in platelets have been obtained either in vitro or using whole body gene deletion that affects vessel wall function. Here we have generated mice with sGC gene deleted only in megakaryocytes and platelets. Using the megakaryocyte- and platelet-specific sGC-deficient mice, we identify a stimulatory role of sGC in platelet activation and in thrombosis in vivo. Deletion of sGC in platelets abolished cGMP production induced by either NO donors or platelet agonists, caused a marked defect in aggregation and attenuated secretion in response to low doses of collagen or thrombin. Importantly, megakaryocyte- and platelet-specific sGC deficient mice showed prolonged tail-bleeding times and impaired FeCl₃-induced carotid artery thrombosis in vivo. Interestingly, the inhibitory effect of the NO donor SNP on platelet activation was sGC-dependent only at micromolar concentrations, but sGC-independent at millimolar concentrations. Together, our data demonstrate important roles of sGC in stimulating platelet activation and in vivo thrombosis and hemostasis, and sGC-dependent and -independent inhibition of platelets by NO donors.

[1]  J. Tamargo,et al.  Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure. , 2010, Current opinion in investigational drugs.

[2]  K. Naseem,et al.  Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: The potential role for S-nitrosylation , 2009, Platelets.

[3]  A. Friebe,et al.  The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. , 2009, Nitric oxide : biology and chemistry.

[4]  Xiaoping Du,et al.  Two Waves of Platelet Secretion Induced by Thromboxane A2 Receptor and a Critical Role for Phosphoinositide 3-Kinases* , 2003, Journal of Biological Chemistry.

[5]  X. Xi,et al.  A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3. , 2001, The Journal of biological chemistry.

[6]  R. Haslam,et al.  Effects of collagen and of aspirin on the concentration of guanosine 3':5'-cyclic monophosphate in human blood platelets: measurement by a prelabelling technique. , 1974, The Biochemical journal.

[7]  Aneesa Fasim,et al.  Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration. , 2006, Nitric oxide : biology and chemistry.

[8]  S. Day,et al.  Murine thrombosis models , 2004, Thrombosis and Haemostasis.

[9]  G. Schultz,et al.  Expression of soluble guanylyl cyclase , 1990, FEBS letters.

[10]  F. Murad,et al.  Expression of soluble guanylate cyclase activity requires both enzyme subunits. , 1991, Biochemical and biophysical research communications.

[11]  F. Murad,et al.  The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion. , 2010, European journal of pharmacology.

[12]  A. Kang,et al.  Effect of cyclic 3',5'-guanosine monophosphate on human platelet function. , 1976, The Journal of laboratory and clinical medicine.

[13]  N. Hay,et al.  A Phosphoinositide 3-Kinase-AKT-Nitric Oxide-cGMP Signaling Pathway in Stimulating Platelet Secretion and Aggregation* , 2006, Journal of Biological Chemistry.

[14]  Aleksandra Stojanovic,et al.  Signaling-mediated Functional Activation of Inducible Nitric-oxide Synthase and Its Role in Stimulating Platelet Activation* , 2008, Journal of Biological Chemistry.

[15]  U. Walter,et al.  NO‐synthase‐/NO‐independent regulation of human and murine platelet soluble guanylyl cyclase activity , 2008, Journal of thrombosis and haemostasis : JTH.

[16]  R. Scharpf,et al.  Regulation of platelet granule exocytosis by S-nitrosylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Félétou,et al.  Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase. , 2010, Vascular pharmacology.

[18]  N. Hay,et al.  The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. , 2008, Blood.

[19]  J. Freedman,et al.  Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. , 2005, American journal of physiology. Heart and circulatory physiology.

[20]  Ka Bian,et al.  Discovery of the nitric oxide signaling pathway and targets for drug development. , 2009, Frontiers in bioscience.

[21]  F. Murad,et al.  Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Morris,et al.  A Gi‐independent mechanism mediating Akt phosphorylation in platelets , 2010, Journal of thrombosis and haemostasis : JTH.

[23]  C. Lowenstein,et al.  Nitric oxide regulation of protein trafficking in the cardiovascular system. , 2007, Cardiovascular research.

[24]  J. Mehta,et al.  Identification of constitutive and inducible forms of nitric oxide synthase in human platelets. , 1995, The Journal of laboratory and clinical medicine.

[25]  A. Friebe,et al.  Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. , 2006, The Journal of clinical investigation.

[26]  A. Friebe,et al.  Nitric oxide‐sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition , 2010, Journal of thrombosis and haemostasis : JTH.

[27]  J. Mehta,et al.  Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. , 1996, Journal of cardiovascular pharmacology.

[28]  F. Hofmann,et al.  cGMP regulated protein kinases (cGK). , 2009, Handbook of experimental pharmacology.

[29]  Aleksandra Stojanovic,et al.  Stimulatory Roles of Nitric-oxide Synthase 3 and Guanylyl Cyclase in Platelet Activation* , 2005, Journal of Biological Chemistry.

[30]  H. Ischiropoulos,et al.  Tyrosine nitration: Localisation, quantification, consequences for protein function and signal transduction , 2001, Free radical research.

[31]  V. O’Donnell,et al.  Nitrolinoleate Inhibits Platelet Activation by Attenuating Calcium Mobilization and Inducing Phosphorylation of Vasodilator-stimulated Phosphoprotein through Elevation of cAMP* , 2002, The Journal of Biological Chemistry.

[32]  I. Lizasoain,et al.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Daugherty,et al.  Measuring Blood Pressure in Mice using Volume Pressure Recording, a Tail-cuff Method , 2009, Journal of visualized experiments : JoVE.

[34]  D. Koesling.  Studying the structure and regulation of soluble guanylyl cyclase. , 1999, Methods.

[35]  G. Zoidl,et al.  Major occurrence of the new α2β1 isoform of NO-sensitive guanylyl cyclase in brain , 2003 .

[36]  Xiaoping Du,et al.  A Mitogen-activated Protein Kinase-dependent Signaling Pathway in the Activation of Platelet Integrin αIIbβ3 * , 2001, The Journal of Biological Chemistry.

[37]  Xiaoping Du,et al.  A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans. , 2003, Blood.

[38]  U. Walter,et al.  Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase. , 2004, Blood.

[39]  W. Hong,et al.  Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. , 2006, Molecular biology of the cell.

[40]  A. Friebe,et al.  Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase , 2007, Proceedings of the National Academy of Sciences.

[41]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Hofmann,et al.  A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation , 2003, Cell.

[43]  P. Klatt,et al.  Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.

[44]  U. Förstermann,et al.  Identification of the NO Synthase isoforms Expressed in Human Neutrophil Granulocytes, Megakaryocytes and Platelets , 1997, Thrombosis and Haemostasis.

[45]  R. Haslam,et al.  Regulation of blood platelet function by cyclic nucleotides. , 1978, Advances in cyclic nucleotide research.